Michael Milligan
Direttore Finanziario/CFO presso New Haven Pharmaceuticals, Inc.
Profilo
Michael Milligan is currently the Chief Financial Officer & Executive Vice President at New Haven Pharmaceuticals, Inc. He holds an MBA from Georgia State University and an undergraduate degree from the University of Miami.
Posizioni attive di Michael Milligan
| Società | Posizione | Inizio |
|---|---|---|
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Direttore Finanziario/CFO | - |
Formazione di Michael Milligan
| Georgia State University | Masters Business Admin |
| University of Miami | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Health Technology |
- Borsa valori
- Insiders
- Michael Milligan
